MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Alpha-synuclein"

  • 2019 International Congress

    Systematic Assessment of 10 diagnostic marker candidates in biological fluids for Parkinson’s disease

    B. Mollenhauer, R. Gera, N. Kruse, R. Barbour, W. Zago, S. Schade, B. Otte, C. Trenkwalder (South San Francisco, CA, USA)

    Objective: To validate in serum and/or cerebrospinal fluid (CSF) diagnostic biomarker candidates identified from a systematic literature search including markers on axonal and synaptic integrity,…
  • 2019 International Congress

    Amylin deposition in the brain of Parkinson’s disease patients

    I. Martinez-Valbuena, R. Valenti-Azcarate, J. Sanchez, I. Marcilla Garcia, G. Marti Andres, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)

    Objective: The objective of this study was to determine the presence of amylin deposits in the brain of subjects with synucleinopathies. Background: The link between…
  • 2019 International Congress

    Ginsenoside Rb1 Prevents MPTP-Induced Changes in Hippocampal Memory via Regulation of the α-Synuclein/PSD-95 Pathway

    S. Qu, Y. Zhang, X. Meng, Y. Liu, X. Zhang (Foshan, China)

    Objective: To explore the effects of ginsenoside Rb1 on the cognitive impairment of Parkinson’s disease (PD) model. Background: Memory deficiency is a common non-motor symptom…
  • 2019 International Congress

    GBA1 biomarkers in longitudinal CSF: GCase, Sphingolipids and alpha-synuclein

    S. Lerche, C. Schulte, G. Machetanz, I. Wurster, B. Röben, M. Zimmermann, C. Deuschle, A. Hauser, I. Liepelt-Scarfone, J. Böhringer, I. Krägeloh-Mann, I. Lachmann, W. Maetzler, T. Gasser, M. Mielke, D. Berg, K. Brockmann (Tuebingen, Germany)

    Objective: To assess the GBA1-pathway-specific biomarker profile in patient-derived CSF. Background: Heterozygous mutations in the GBA1 gene represent the most common genetic risk factor for…
  • 2019 International Congress

    Investigation of the protective efficacy of alpha-synuclein-specific antibodies in a novel neuronal cell model for synucleinopathies

    A. Peukert, M. Höllerhage, W. Zago, G. Höglinger (Munich, Germany)

    Objective: To investigate the protective efficacy of different alpha-synuclein (α-Syn)-targeting antibodies in a new model of α-Syn cell-to-cell spread. Background: The 14 kDa protein α-Syn…
  • 2019 International Congress

    Parkinson’s disease-associated mutations of PLA2G6 alters the membrane dynamics and α-synuclein stability

    a. Mori, T. Hatano, T. Inoshita, K. Shiba-Fukushima, T. Koinuma, C. Yamashita, A. Okuzumi, Y. Imai, n. Hattori (Tokyo, Japan)

    Objective: To investigate the mechanism of α-synuclein (α-Syn) aggregation. Background: PLA2G6 has been isolated as the gene responsible for an autosomal recessive form of Parkinson’s…
  • 2019 International Congress

    Cognitive ability characterization of rat model with mutated alpha-synuclein overexpression

    C. Laloux, C. Lachaud, K. Timmerman, E. Bezard, R. Bordet, D. Devos (Lille, France)

    Objective: The present study aims to assess cognitive function in a rat model of mutated alpha-synuclein overexpression in order to determine whether this model can…
  • 2019 International Congress

    Dementia with Lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile

    S. Lerche, G. Machetanz, I. Wurster, B. Roeben, M. Zimmermann, A. Pilotto, A-K. Hauser, C. Schulte, I. Lachmann, T. Gasser, D. Berg, W. Maetzler, K. Brockmann (Tübingn, Germany)

    Objective: Whether GBA1 mutations are associated with a CSF alpha-synuclein profile in DLB. Background: Patients with dementia with Lewy bodies (DLB) reveal a variable pathology…
  • 2019 International Congress

    Wide distribution of alpha-synuclein oligomers in Creutzfeldt-Jakob disease detected by a novel proximity ligation assay

    R. Valenti-Azcarate, I. Martinez-Valbuena, C. Caballero, I. Marcilla Garcia, G. Marti, M. Carmona-Abellan, M. Tuñon-Alvarez, MR. Luquin-Piudo (Pamplona, Spain)

    Objective: The objective of this work is to assess if oligomeric forms of alpha-synuclein exist in patients with Creutzfeldt-Jakob disease. Background: Prion diseases, the most…
  • 2019 International Congress

    High repressive activity of olive extracts on the cell line model of Parkinson disease against ROS induction

    D. Morshedi (Tehran, Islamic Republic of Iran)

    Objective: Neurodegenerative diseases including Parkinson’s disease (PD) mostly accompany with induction of high ROS in neuronal cells. It is believed that unusual level of ROS…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley